James Askew1, Saxon Connor1. 1. Department of Surgery, Christchurch Hospital, Christchurch, New Zealand.
Abstract
BACKGROUND: Ampullary adenocarcinoma is considered to have a better prognosis than either pancreatic or bile duct adenocarcinoma. Pancreaticoduodenectomy is associated with significant mortality and morbidity. Some recent publications have advocated the use of endoscopic papillectomy for the treatment of early ampullary adenocarcinoma. This article reviews investigations and surgical treatment options of ampullary tumours. METHODS: A systematic review of English-language articles was carried out using an electronic search of the Ovid MEDLINE (from 1996 onwards), PubMed and Cochrane Database of Systematic Reviews databases to identify studies related to the investigation and management of ampullary tumours. RESULTS: Distinguishing between ampullary adenoma and adenocarcinoma is challenging given the inaccuracy of endoscopic biopsy, for which high false negative rates of 25-50% have been reported. Endoscopic ultrasound is the most accurate method for local staging of ampullary lesions, but distinguishing between T1 and T2 adenocarcinomas is difficult. Lymph node metastasis occurs early in the disease process; it is lowest for T1 tumours, but the risk is still high at 8-45%. Case reports of successful endoscopic resection and transduodenal ampullectomy of T1 adenocarcinomas have been published, but their duration of follow-up is limited. CONCLUSIONS: Optimal staging should be used to distinguish between ampullary adenoma and adenocarcinoma. Pancreaticoduodenectomy remains the treatment of choice for all ampullary adenocarcinomas.
BACKGROUND:Ampullary adenocarcinoma is considered to have a better prognosis than either pancreatic or bile duct adenocarcinoma. Pancreaticoduodenectomy is associated with significant mortality and morbidity. Some recent publications have advocated the use of endoscopic papillectomy for the treatment of early ampullary adenocarcinoma. This article reviews investigations and surgical treatment options of ampullary tumours. METHODS: A systematic review of English-language articles was carried out using an electronic search of the Ovid MEDLINE (from 1996 onwards), PubMed and Cochrane Database of Systematic Reviews databases to identify studies related to the investigation and management of ampullary tumours. RESULTS: Distinguishing between ampullary adenoma and adenocarcinoma is challenging given the inaccuracy of endoscopic biopsy, for which high false negative rates of 25-50% have been reported. Endoscopic ultrasound is the most accurate method for local staging of ampullary lesions, but distinguishing between T1 and T2 adenocarcinomas is difficult. Lymph node metastasis occurs early in the disease process; it is lowest for T1 tumours, but the risk is still high at 8-45%. Case reports of successful endoscopic resection and transduodenal ampullectomy of T1 adenocarcinomas have been published, but their duration of follow-up is limited. CONCLUSIONS: Optimal staging should be used to distinguish between ampullary adenoma and adenocarcinoma. Pancreaticoduodenectomy remains the treatment of choice for all ampullary adenocarcinomas.
Authors: Douglas G Adler; Waqar Qureshi; Raquel Davila; S Ian Gan; David Lichtenstein; Elizabeth Rajan; Bo Shen; Marc J Zuckerman; Robert D Fanelli; Trina Van Guilder; Todd H Baron Journal: Gastrointest Endosc Date: 2006-12 Impact factor: 9.427
Authors: Jae Hoon Lee; Kyeong Geun Lee; Tae Kyung Ha; Young Jin Jun; Seung Sam Paik; Hwon Kyum Park; Kwang Soo Lee Journal: Am Surg Date: 2011-03 Impact factor: 0.688
Authors: S M M de Castro; N T van Heek; K F D Kuhlmann; O R C Busch; G J A Offerhaus; T M van Gulik; H Obertop; D J Gouma Journal: Surgery Date: 2004-11 Impact factor: 3.982
Authors: Lawrence H Schwartz; Robert A Lefkowitz; David M Panicek; Fergus V Coakley; William Jarnagin; Ronald Dematteo; Yuman Fong; Leslie Blumgart Journal: J Comput Assist Tomogr Date: 2003 May-Jun Impact factor: 1.826
Authors: Jessica B O'Connell; Melinda A Maggard; Jesse Manunga; James S Tomlinson; Howard A Reber; Clifford Y Ko; O Joe Hines Journal: Ann Surg Oncol Date: 2008-03-28 Impact factor: 5.344
Authors: Tainara F Felix; Rainer M Lopez Lapa; Márcio de Carvalho; Natália Bertoni; Tomas Tokar; Rogério A Oliveira; Maria A M Rodrigues; Cláudia N Hasimoto; Walmar K Oliveira; Leonardo Pelafsky; César T Spadella; Juan C Llanos; Giovanni F Silva; Wan L Lam; Silvia Regina Rogatto; Luciana Schultz Amorim; Sandra A Drigo; Robson F Carvalho; Patricia P Reis Journal: PLoS One Date: 2019-05-31 Impact factor: 3.240